SUMMARY A double-blind stratified treatment trial was carried out on 108 patients with moderate to severe trachoma in a village in Southern Iran to assess the efficacy of topical therapy of I % rifampicin eye ointment or 1 % spiramycin eye ointment in comparison with 1 % oxytetracycline eye ointment. A 6-week course of treatment with the antibiotics used twice daily produced a cure rate of 67 % for rifampicin, 56% for oxytetracycline, and 64% for spiramycin when the upper tarsal conjunctiva was examined 1 week after completion of treatment. Seven months later the number of patients still free from active trachoma was reduced considerably. When the whole conjunctiva was examined, the cure rate for all 3 antibiotics was considerably lower than that obtained by examining the upper tarsus alone. The marked difference in response to treatment between the upper tarsus and the whole conjunctiva was due mainly to the presence of residual mild trachomatous inflammation in the upper fornix and the lower lid conjunctiva. The follow-up investigations revealed that this residual inflammation in the upper fornix and the lower lid is related to an increased risk of recurrence of inflammation in the whole conjunctiva, including the upper tarsal area. Microbiologically, after treatment with the antibiotics the isolation rate fell from 18-19% to 2-4%. Seven months later the isolation rate in the group treated with rifampicin or oxytetracycline remained low, whereas in the group treated with spiramycin this was raised to a level of 27 %.
amined for signs of active trachoma. Children with moderate to severe grades of trachomatous conjunctival inflammation (Dawson et al., 1975b) were included in this study.
CLINICAL EXAMINATION
Clinical signs observed with a Haag-Streit 900 slit-lamp were recorded on proformas by an extension of the scoring system used for the study of trachoma (Dawson et al., 1975b) . The clinical signs observed in different areas of the palpebral conjunctiva, namely upper tarsus (UT), upper fornix (UF), lower tarsus (LT), and lower fornix (LF), were graded on a 0-3 scale and recorded for each area separately. The intensity of inflammation in the upper tarsal area or the whole conjunctiva (WC) was calculated by a modified version of the system proposed by Dawson et al. (1975b) (Table 1) . PHOTOGRAPHIC 
DOCUMENTATION
Each area of the palpebral conjunctiva, namely, UT, UF, LT, and LF, and the limbus of each eye were photographed with a camera unit designed for this purpose (Jones and Sheen, in preparation) and Kodachrome II film.
The colour transparencies were subsequently examined in London, the clinical signs being quantified by 3 ophthalmologists following the method used during clinical examination. In case of disagreement among the observers transparencies were re-examined and compared with a standard set.
LABORATORY INVESTIGATIONS
Conjunctival swabbings collected from the upper tarsus, upper fornix, and the lower lid (LL) conjunctiva of the right and left eyes were placed together in a plastic capsule containing 2SP transport mediuni (Gordon et al., 1969) with additional 3% fetal calf serum and stored in a liquid nitrogen refrigerator (-180°C) until transported to the Chi-square significance tests were used for a comparison of results.
Results
Initially 148 patients with moderate to severe trachoma (grades 3 or 4) in their whole conjunctiva were included in this trial. Of these, 40 were excluded, 22 due to inadequate treatment or follow-up and 18 because of the development of an adverse reaction to spiramycin. The allocation of the 108 remaining patients to the 3 treatment groups and their age and sex distribution are shown in Table 2 . Because of the close correlation observed between the results of screening transparencies and the clinical examination, and the high repeatability of scoring inflammatory changes by photography, the efficacy of treatment in this trial was assessed by scoring coded transparencies taken before and at intervals after the treatment.
When the upper tarsus alone was examined (the conventional method) 1 week after completion of treatment, the cure rate for rifampicin was 67% compared with 56% for oxytetracycline and 64% for spiramycin (Table 3 and Fig. 1 ). The beneficial effects of treatment with each of the 3 antibiotics were statistically significant (P<005). The differences between the efficacy of these antibiotics were not statistically significant. At the follow-up examination 7 months later the number of patients who were still free from active trachoma was reduced to 36% for rifampicin compared with 32% for oxytetracycline and 27% for spiramycin (Table 3 and Fig. 1 ). When the trachomatous inflammatory changes were assessed in the whole conjunctiva, the cure rate for all 3 antibiotics was considerably lower than that obtained by examining the upper tarsus alone (Table 4 and Fig. 2 ). When the whole conjunctiva was examined 1 week after completion of treatment, the cure rate for rifampicin was 38% compared with 27% for oxytetracycline and 18% for spiramycin (Table 4 and Fig. 2 ). In the second follow-up 4 months later the number of patients still free from trachoma in the rifampicin group (40%) was higher than those treated with oxytetracycline (20%) or spiramycin (14%). This difference reaches statistical significance at a level of 5% (P<005). However, this advantage of rifampicin was no longer significant at the third follow-up examination 7 months later. In those patients who were not cured, the intensity of inflammatory changes in the upper tarsus as well as the whole conjunctiva was markedly reduced after the treatment with the 3 antibiotics ( Figs. 1  and 2 ). The number of patients with grades 3 and 4 fell to 4% after treatment with rifampicin compared with 12% for oxytetracycline and 14% for spiramycin (Fig. 2) . In the second follow-up 4 months later the intensity of inflammation in those patients who were not cured was significantly less with rifampicin than with either of the other 2 antibiotics (Figs. 1 and 2) (P<0 05). This difference was not observed during the third follow-up.
The marked difference in responses to treatment between the upper tarsus and the whole conjunctiva was mainly due to the presence of residual mild trachomatous inflammation (grade 2) in the upper fomix and lower lid conjunctiva (Figs. 1 and 2) . However, the follow-up studies in all groups treated with antibiotics showed that residual mild inflammation in the upper fornix and lower lid Mild trachoma Inactive conjunctiva is related to an increased risk of recrudescence of inflammation in the whole conjunctiva, including the upper tarsal area (Table 5) .
No marked differences in response to treatment were observed between different age groups except in babies under 1 year old, who showed a poor response to treatment. There was no significant difference between males and females in response to treatment.
Microbiologically between 18 and 19% of patients allocated to each treatment group were positive for (Table 2) .
The treatment trial was designed to test the efficacy of different topical drugs on hyperendemic trachoma under field conditions. The eye ointments were applied twice daily. This schedule is more practical than thrice daily applications of ointment in the rural areas of Iran, where during the day adults, mostly accompanied by their young children, are working on their farms. During the 6-week course of treatment the total number of ointments applied was 84.
Examination of the upper tarsus alone 1 week after the completion of treatment showed a moderate cure rate for rifampicin, oxytetracycline, and spiramcyin (56% to 67%). The intensity of disease was also reduced considerably in patients who were not cured. At the follow-up examination 7 months later the number of patients free from trachoma in all groups was halved (27% to 36%) and the intensity of disease increased markedly.
When the inflammatory changes of trachoma in the whole conjunctiva were assessed, the cure rate for all 3 antibiotics was markedly lower than that obtained by examining the upper tarsal conjunctiva alone. This difference was due to the presence of active but mild to moderate trachoma in the fomices of some of the patients with normal upper tarsal conjunctiva. In this group of patients (with normal upper tarsal conjunctiva but with active trachoma in their fornices) the rate of recurrence or recrudescence of moderate to severe trachoma was twice as high as in those who showed no active trachomatous inflammation in their whole conjunctiva, including the upper tarsus (Table 5) .
In Tunisia treatment of hyperendemic trachoma with rifampicin or tetracycline ointments twice daily for a course of 10 weeks was shown to be beneficial in suppressing the disease but not in eradicating the infection (Dawson et al., 1975a) .
In London treatment of paratrachoma (inclusion conjunctivitis, TRIC punctate keratoconjunctivitis and trachoma) of sexually transmitted origin (Jones, 1975) with rifampicin eye ointment 3 times daily for 6 to 7 weeks was shown to eradicate the infection in 90% of patients (Darougar et al., 1977) . However, in the absence of apparent differences in the sensitivity of prototypes of TRIC agent serotypes as well as wild TRIC agent isolates to rifampicin, tetracyclines, and spiramycin (Trehame et al., 1977) it can be argued that in the present study the lower cure rate obtained with rifampicin may be due to the suboptimal daily applications of the ointment or to a shorter course of treatment.
In this trial a control group was not included to assess the degree of natural decline in the intensity of trachoma with the lapse of time, increasing age, or seasonal variations. However, studies in Tunisia have shown that in children under the age of 6-7 with moderate to severe trachoma the intensity of inflammatory changes in the conjunctiva remains fairly constant in a period of 1 year (Dawson et al., 1975a) . In the present study the majority of the patients included were children under the age of 7 with moderate to severe trachoma, and the course of follow-up was up to 7 months. Therefore it can be argued that the beneficial effect obtained in this trial is probably caused mainly by chemotherapy and not by the natural decline in the intensity of trachoma.
Immediately after completion of treatment the efficacy of topical therapy with rifampicin was very similar to that of oxytetracycline or spiramycin. In the second follow-up (4 months later) rifampicin appeared clinically to be superior to oxytetracycline or spiramycin by having fewer recurrences. In the last follow-up (7 months later) this difference was no longer present. At this time the cure rates for all 3 antibiotics were as low as 20% (whole conjunctiva). In this study the children in the trial were living with other untreated children and adults in the village, and no attempt was made to reduce the possibility of reinfections in these children by treating their families.
Microbiologically the chlamydial isolation rate before treatment was similar in the 3 groups (18-19%) . At the last follow-up (7 months later) the isolation rate in groups treated with rifampicin or oxytetracycline remained low, whereas in the group treated with spiramycin it was increased to a level of 27%. The microbiological response to treatment with rifampicin or oxytetracycline obtained in this study is similar to those reported in trials in Tunisia (Dawson et al., 1975a) and London (Darougar et al., 1977) .
In the group treated with spiramycin 18 patients developed moderate to severe adverse reactions. Bacterial cultures of samples of spiramycin ointments used in this study showed no growth. In London no adverse reaction was observed in patients with chlamydial, viral, or bacterial conjunctivitis who were treated with spiramycin eye ointment from the same batch. Although contact dermatitis due to spiramycin eye ointment has been reported previously (Hurwitz, 1959) , the cause of this unusual reaction in children in Iran remains obscure.
In evaluating the effect of trachoma chemotherapy with rifampicin, oxytetracycline, or spiramycin we conclude that, though topical therapy with these antibiotics twice daily for 6 weeks is suboptimal, it may convert blinding trachoma in a community into a nonblinding disease (Dawson et al., 1975b) if applied to the entire population. 
